Companies: 10,795·Total market cap: $144.5T

Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

PLSENASDAQHealthcare● Active

$24.84

$-0.49(-1.93%)

Market Cap$1.7B

P/E Ratio—

52W High$27.98

52W Low$12.56

Avg Volume301K

Open$25.59

Beta1.66

Net Income Financials Revenue

Pulse Biosciences, Inc. (PLSE) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

PLSE · net income · updated Jun 8, 2026

Core profitability metrics

PLSE · net income · margin · TTM · CAGR

Net income was −$72.8M for FY2025 (fiscal year ending 2025-12-31), down 35.8% year-over-year. Net profit margin was -20794.6%.

FY2025 Net Income−$72.8M▼ -35.8% YoY

Trailing 12M (TTM)−$74.6Mtrailing 4 quarters sum

Net Profit Margin< −999%−$72.8M ÷ $350,000

YoY Change-35.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · PLSE net income history · PLSE profit margin

Annual net income data

PLSE · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$72.8M▼ 35.8%-20794.6%$350,000

FY2024Loss−$53.6M▼ 26.9%—$0

FY2023Loss−$42.2M▲ +27.9%—$0

FY2022Loss−$58.5M▲ +8.1%-8357.9%$700,000

FY2021Loss−$63.7M▼ 28.0%-4489.4%$1.4M

Net income vs peers (Healthcare)

PLSE vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Pulse Biosciences, Inc.YOU

PLSE

−$72.8M-35.8%-20794.6%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Pulse Biosciences, Inc. (PLSE) reported net income of −$72.8M for FY2025 (fiscal year ending 2025-12-31), down 35.8% year-over-year. The net profit margin was -20794.6% — meaning the company kept $-207.95 of every dollar of revenue as profit.

Pulse Biosciences, Inc. has not yet achieved annual profitability based on available data (12 fiscal years). The company has reported net losses across all available periods.

Pulse Biosciences, Inc.'s net profit margin was -20794.6% for FY2025, based on the latest annual results.

Investors sometimes search for "Pulse Biosciences, Inc. net worth" — the company's market capitalization is a separate figure from PLSE net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

PLSE net income · 4 questions

Pulse Biosciences, Inc. is not currently profitable on an annual basis. The company reported a net loss of $72.8M for FY2025.

is PLSE profitabledoes PLSE make a profitPLSE profitabilityPLSE profitable company

▸ Source: FMP /income-statement · GAAP · Pulse Biosciences, Inc. · Pulse Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026